Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

GlaxoSmithKline plc (ADR) Company Profile (NYSE:GSK)

Consensus Ratings for GlaxoSmithKline plc (ADR) (NYSE:GSK) (?)
Ratings Breakdown: 3 Sell Rating(s), 13 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $50.67 (14.09% upside)

Current Analysts' Coverage Summary for GlaxoSmithKline plc (ADR) (NYSE:GSK)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/21/2014ZacksReiterated RatingUnderperform -> Underperform$40.00ViewTweet This Rating  Share This Rating on StockTwits
10/16/2014Deutsche BankReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
10/15/2014Credit SuisseReiterated RatingUnderperformViewTweet This Rating  Share This Rating on StockTwits
10/14/2014JPMorgan Chase & Co.Reiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
9/30/2014Panmure GordonReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
9/30/2014Jefferies GroupReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
9/22/2014Goldman SachsUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
9/19/2014KillikReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
8/8/2014ArgusLower Price TargetBuy$65.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
8/4/2014Galvan ResearchReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
7/28/2014Main First Bank AGDowngradeUnderperformViewTweet This Rating  Share This Rating on StockTwits
7/28/2014Bank of AmericaDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
7/24/2014BarclaysReiterated RatingEqual WeightViewTweet This Rating  Share This Rating on StockTwits
6/20/2014Liberum CapitalReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
4/28/2014Shore CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/23/2014Societe GeneraleReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/23/2014Beaufort SecuritiesReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/12/2014Citigroup Inc.Reiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
1/27/2014S&P Equity ResearchUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
1/24/2014Berenberg BankDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
1/22/2014Cowen and CompanyDowngradeOutperform -> Market Perform$57.00ViewTweet This Rating  Share This Rating on StockTwits
12/16/2013MacquarieUpgradeNeutralViewTweet This Rating  Share This Rating on StockTwits
8/15/2013Morgan StanleyDowngradeEqual Weight -> UnderweightViewTweet This Rating  Share This Rating on StockTwits
6/12/2013TheStreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/25/2013BNP ParibasReiterated RatingUnderperformViewTweet This Rating  Share This Rating on StockTwits
4/22/2013Espirito Santo Investment Bank ResearchReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
4/3/2013Numis Securities LtdReiterated RatingHold$154.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/23/2012 forward)
Discuss GlaxoSmithKline plc (ADR)